Growth Metrics

Electromed (ELMD) Other financing activities (2010 - 2026)

Electromed (ELMD) reported Other financing activities of $30000.0 for Q1 2026, up 107.56% year-over-year from $14453.9 in Q1 2025, and down 53.12% on a QoQ basis from $64000.0 in Q4 2025.

Electromed (ELMD) has 9 years of Other financing activities data on file, last reported at $30000.0 in Q1 2026.

  • Quarterly Other financing activities rose 107.56% year-over-year to $30000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39000.0 (up 102.06% YoY) and the FY2025 annual result came in at -$1.9 million, down 713.18% from the prior year.
  • Other financing activities retreated to $30000.0 in Q1 2026 per ELMD's latest filing, from $64000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $250000.0 in Q1 2024 and bottomed at -$830000.0 in Q4 2024.
  • The 4-year median for Other financing activities is $6000.0 (2024), against an average of -$140636.4.
  • The widest annual swing landed in 2024, when Other financing activities plunged 3292.31%; it then soared 107.71% in 2025.
  • Tracing ELMD's Other financing activities over 4 years: stood at $26000.0 in 2023, then sank by 3292.31% to -$830000.0 in 2024, then surged by 107.71% to $64000.0 in 2025, then plunged by 53.12% to $30000.0 in 2026.
  • Per Business Quant, the three latest ELMD Other financing activities figures stand at $30000.0 (Q1 2026), $64000.0 (Q4 2025), and -$45000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Electromed 300.53 Mn 283.55 Mn 14.64 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 30,000.00
Mar 31, 2026 30,000.00
Dec 31, 2025 64,000.00
Dec 31, 2025 64,000.00
Sep 30, 2025 -45,000.00
Sep 30, 2025 -45,000.00
Jun 30, 2025 -10,000.00
Jun 30, 2025 -10,000.00
Mar 31, 2025 -397,000.00
Mar 31, 2025 -397,000.00
Dec 31, 2024 -830,000.00
Dec 31, 2024 -830,000.00
Sep 30, 2024 -670,000.00
Sep 30, 2024 -670,000.00
Jun 30, 2024 6,000.00
Jun 30, 2024 6,000.00
Mar 31, 2024 250,000.00
Mar 31, 2024 250,000.00
Dec 31, 2023 26,000.00
Dec 31, 2023 26,000.00
Sep 30, 2023 29,000.00
Sep 30, 2023 29,000.00
Dec 31, 2021 -6,000.00
Dec 31, 2021 -6,000.00
Sep 30, 2021 -64,000.00
Sep 30, 2021 -64,000.00
Jun 30, 2021 117.00
Jun 30, 2021 117.00
Mar 31, 2021 -11,117.00
Mar 31, 2021 -11,117.00
Dec 31, 2020 -10,000.00
Dec 31, 2020 -10,000.00
Sep 30, 2020 -120,000.00
Sep 30, 2020 -120,000.00
Mar 31, 2012 787.00
Mar 31, 2012 787.00
Jun 30, 2011 -1.00
Jun 30, 2011 -1.00
Mar 31, 2011 2,058.00
Mar 31, 2011 2,058.00
Sep 30, 2010 4,659.00
Sep 30, 2010 4,659.00